Search company, investor...

Predict your next investment

Investments

3

Portfolio Exits

1

About NewcoGen Group

Headquarters Location

Want to inform investors similar to NewcoGen Group about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

NewcoGen Group Investments

3 Investments

NewcoGen Group has made 3 investments. Their latest investment was in Selventa as part of their Series A on August 8, 2003.

CBI Logo

NewcoGen Group Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/21/2003

Series A

Selventa

$1.05M

Yes

8/24/2001

Series B

Subscribe to see more

$99M

Subscribe to see more

0

11/9/2000

Series A

Subscribe to see more

$99M

Subscribe to see more

0

Date

8/21/2003

8/24/2001

11/9/2000

Round

Series A

Series B

Series A

Company

Selventa

Subscribe to see more

Subscribe to see more

Amount

$1.05M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

0

0

NewcoGen Group Portfolio Exits

1 Portfolio Exit

NewcoGen Group has 1 portfolio exit. Their latest portfolio exit was Bg Medicine on February 21, 2011.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/21/2011

IPO

$99M

Public

Date

2/21/2011

Exit

IPO

Companies

Valuation

$99M

Acquirer

Public

Sources

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.